 HOUSTON, Jan. 8, 2021 PRNewswire -- Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. NASDAQ: ATOS , recently shared his latest research and findings regarding the origins of COVID-19 and the manner in which it spread so quickly... 